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In this study, a novel technique for screening inhibitors by electrospray mass spectrometry
(ESI-MS) with immobilized enzyme on magnetic microspheres has been demonstrated. First,
the model enzyme acetylcholinesterase (AChE) is immobilized onto the 3-glycidoxypropylt-
rimethoxysilane (GLYMO)-modified magnetic silica microspheres. AChE activity was moni-
tored by biochemical assay that is based on mixing of AChE immobilized microspheres and
model substrate acetylcholine, separating and detecting the product through ESI-MS. Stability
of the enzyme-immobilized microspheres was investigated. No apparent loss of enzyme
activity was observed after fivefold reuse of AChE-immobilized microspheres. The enzyme-
immobilized bioassay was used to effectively identify AChE inhibitors among two standard
samples, huperzine A and huperzine B, and their source herbal Huperzia serrata, all of which
were spiked into the substrate. The inhibition was determined by measuring a decrease of
product formation using ESI-MS. (J Am Soc Mass Spectrom 2008, 19, 865–873) © 2008
American Society for Mass SpectrometryThe enzyme acetylcholinesterase (AChE) plays apivotal role in the nervous system. The principalfunction of this enzyme is the termination of
nerve impulse transmission at the cholinergic synapses
by rapid hydrolysis of the active neurotransmitter ace-
tylcholine (ACh) into the inactive compounds choline
and acetic acid. Low levels of ACh in the synaptic cleft
are associated with Alzheimer’s disease (AD), the most
frequent disease affecting elderly people. Inhibition of
AChE activity serves as a strategy for the treatment of
AD [1–3]. Several synthetic drugs, such as galan-
thamine, have been approved for treatment of AD in
the United States and some European countries [4–6].
They act as acetylcholinesterase inhibitors (AChEIs)
and therefore increase the amount of free ACh, which
results in neuron transmission improvement [7]. Unfor-
tunately, the available treatments are not satisfactory
(undesirable side effects, low efficiency), and there is
still a need for original drug development.
Techniques focusing on the enzyme model are well
implemented in current pharmaceutical studies. Re-
cently, some AChE assays based on colorimetrics have
been described [8, 9]. The biochemical assay was due to
the AChE-catalyzed hydrolysis of the synthetic sub-
strate acetylthiocholine into thiocholine. To obtain col-
orimetric readout, the product thicholine is allowed to
react with an additional reagent to form a yellow-
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doi:10.1016/j.jasms.2008.02.016colored product that is detected by UV-Vis. Besides the
additional reagent, the drawback of this assay is that
compounds present in plant extracts are known to
interface with the second reaction, thereby yielding
false positives.
Immobilization of enzymes on various beads and
surface materials has been widely used because they
provide many advantages over free enzymes including:
(1) reduced autolysis products and sample contamina-
tion [10, 11]; (2) label-free environment [12]; (3) rapid
throughput [13]; (4) the possibility to recycle the studied
enzymes or continuous reuse of the enzymes [14, 15];
(5) easy separation of the product from reaction media
[16–18]; and (6) a multiplexed approach for the inves-
tigation of enzymes, allowing the coupling of different
analytical techniques, such as mass spectrometry [19].
For example, a variety of methods have been reported
for trypsin immobilization on various supports, such as
polymer particles [20], glass [21, 22], membrane [23], gel
beads [24], sol-gel supports [25], porous silicon matrix
[26–28], porous monolithic materials [29–31], and para-
magnetic microparticles [32]. In our group, trypsin has
been immobilized on magnetic microspheres through
covalent binding [33–35]. It has been demonstrated that
good stability and reproducibility were obtained while
the immobilized enzyme can be reused at several times.
Magnetic microspheres draw great attention due to
their ease of isolation from the reaction mixture with the
assistance of a magnetic field.
Mass spectrometry techniques have been widely
reported for detecting the enzymatic digestion of pro-
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onstrated that the immobilized enzymes can substitute
for regular enzymes in protein chemistry protocols with
the help of matrix-assisted laser desorption/ionization
mass spectrometry (MALDI-MS) [22]. Mass spectrome-
try is the standard for trace-level determination of
compounds in complex mixtures [36–38]. Attempts to
carry out the quantitative validation of the measure-
ment of biological compounds were also reported [39,
40]. In the pharmaceutical industry, this has led to the
routine use of these techniques to monitor pharmaco-
kinetics and bioavailability of drug compounds in bio-
logical matrices. Mass spectrometry has also been ap-
plied to measure the conversion of substrates to
products for enzyme assays [41]. Cancilla et al. hyphen-
ated immobilized enzyme technologies and electros-
pray mass spectrometry (ESI-MS) to screen enzyme
inhibitor candidates from complex mixtures [42]. Poten-
tial inhibitors are quickly identified by comparison of
the spectra change in ion intensity before and after
incubation with the immobilized enzyme.
Here, we introduce a very simple and effective
method of immobilization of enzyme directly onto
3-glycidoxypropyltrimethoxysilane (GLYMO)-modified
magnetic silica microspheres. The epoxy group of
GLYMO can easily capture the enzyme via amide-
functionalized groups. The performance of the immo-
bilized enzyme was tested by ESI-MS after incubation
with substrate acetylcholine. To confirm its use in a
pharmaceutical study, we spiked the substrate with two
possible enzyme inhibitors and incubated the mixture
with immobilized AChE. In the absence of inhibitor, the
substrate was converted to acetic acid and product
(choline), whereas in the presence of an inhibitor, this
reaction was quenched. The reactants were subse-
quently analyzed by ESI-MS. These two possible candi-
dates, the lycopodium unsaturated sesquiterpene alka-
loids huperzine A (Hup A) and huperzine B (Hup B)
[43, 44], have demonstrated specific and reversible
inhibition of AChE. Their potencies, especially for Hup
A, are similar or superior to those of the already
clinically approved AChEIs [44, 45]. According to clin-
ical studies, Hup A satisfies all criteria for a potential
new drug in the symptomatic treatment of AD. It has a
long duration of action, a high bioavailability after oral
administration, and has minimal side effects. Further-
more, such inhibitor screening was tested on a tradi-
tional Chinese herbal, Huperzia serrata, a source of Hup
A and Hup B, to demonstrate the feasibility of applica-
tion on a complicated system.
Experimental
Chemical and Materials
3-Glycidoxypropyltrimethoxysilane (GLYMO), acetyl-
cholinesterase (AChE), and acetylcholine (ACh) were
purchased from Sigma Chemicals (St. Louis, MO, USA).
Chlormequat was from Alfa Aesar (Ward Hill, MA,USA). Distilled water was purified by Milli-Q system
(Milford, MA, USA). Huperzine A and huperzine B
were purchased from the Institute for the Control of
Pharmaceutical and Biological Products of China (Bei-
jing, China). Huperzia serrata was purchased from a local
Chinese medicine store in Shanghai province of China.
Other reagents were analytical grade and purchased
from Shanghai Chemical Reagent Co. (Shanghai,
China). Ammonium bicarbonate (10 mM, pH 7.8) was
used as buffer.
Preparation and Characterization of GLYMO-Modified
Magnetic Silica Microspheres. Magnetic silica (MS) mi-
crospheres with core-shell structure were first synthe-
sized in our laboratory. The magnetic microspheres
were synthesized through solvothermal reaction, de-
scribed as follows: 2.70 g of FeCl3 · 6H2O was first
dissolved in 100 mL of ethylene glycol under magnetic
stirring. A yellow clear solution was obtained after
stirring for 0.5 h. Then 7.20 g of NaAc (sodium acetate)
was added to this solution. After being stirred for
another 0.5 h, the resultant solution was transferred into
a Teflon-lined stainless steel autoclave with capacity of
200 mL. The autoclave was sealed and heated at 200 °C
for 8 h and cooled to room temperature. The black
magnetic microspheres were collected by use of a
magnet, followed by washing six times with recycle of
ethanol and deioned water, after which the product was
dried in vacuum at 60 °C for 12 h.
To obtain core-shell MS microspheres with narrow
size distribution and uniform thickness of silica via the
sol-gel approach, magnetic microspheres (0.01 g) were
first treated in HCl aqueous solution (5.0 mL, 2 M)
under ultrasonic vibration for 5 min. Then, the micro-
spheres were thoroughly washed with deionized water
and redispersed in a mixture of ethanol (70.0 g),
deioned water (20.0 g), and concentrated ammonia
aqueous solution (1.0 g, 28 wt %) with the help of
ultrasonication, and a stable dispersion was obtained.
Subsequently, tetraethyl orthosilicate (0.05 g) was
added to the above dispersion under mechanical stir-
ring and the reaction was allowed to proceed for 12 h.
Finally, by use of a magnet, the product was separated
and washed with ethanol and water, and then vacuum
dried at 60 °C for 24 h.
In the final step, 0.05 g core-shell MS microspheres
were dispensed in toluene with 1.5 g GLYMO added.
The mixture was stirred at room temperature for 1 h.
Finally, the mixture was heated to 65 °C for 6 h.
Immobilization of AChE onto MS Microspheres. GLYMO-
modified MS microspheres (3 mg) were transferred to a
0.6 mL Eppendorf (EP) tube and dispersed in 200 L 0.5
mg/mL AChE solution (10 mM NH4HCO3 as buffer,
pH 7.8). The mixture was ultrasonicated for 1 min to
form a homogeneous suspension. Then the suspension
was rotated at 37 °C for 2 h. After that, the supernatant
solution was removed with the help of a magnet. The
retained magnetic microspheres were washed three
usin
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stored at 4 °C before assay. The simple immobilization
is illustrated in Figure 1a.
The UV absorption value of the supernatant solution
was measured at   280 nm and compared to the UV
absorption value of the AChE solution before immobi-
lization to calculate the amount of AChE immobilized
on the MS microspheres.
Acetylcholinesterase Assay
Briefly, the reaction mixture of AChE-immobilized mi-
cropheres (20 L) and substrate (10 L 200 mM acetyl-
choline), in the presence or absence of drug (32 mM
Hup A, 30 mM Hup B, and 7.7 mg/mL H. serrata),
Figure 1. (a) Illustration of synthesis of AChE-im
of biochemical assay without inhibitors by using
diagram of biochemical assay with inhibitors byprepared in buffer to a final volume of 130 L, wasincubated for 30 min at 37 °C. Then a magnet was used
to gather and isolate the microspheres. The supernatant
was removed to a new EP tube and 10 L 200 mM
chlormequat was added into the solution. Finally, an
aliquot of 5 L above supernatant was analyzed by
ESI-MS. The flowchart of the preceding process is
illustrated in Figure 1b, c.
Mass Spectrometry
The ESI-MS was LC-IT-TOF MS-2010A from Shimadzu
(Kyoto, Japan). The mass system consisted of an elec-
trospray ionization (ESI) interface. The ionization pa-
rameters were as follows: positive-ion mode; capillary
voltage 4000 V, end plate voltage 500 V; nebulizing gas
bilized MS microspheres. (b) Schematic diagram
E-immobilized MS microspheres. (c) Schematic
g AChE-immobilized MS microspheres.mo
AChof nitrogen at 35.0 p.s.i.; and drying gas of 10.0 L/min
868 HU ET AL. J Am Soc Mass Spectrom 2008, 19, 865–873nitrogen at 365 °C. The mass analyzer scanned from 100
to 1000 u. The MS spectra were recorded in auto-MS
mode. The fragmentation amplitude was set to 2.0 V.
Extraction of Huperzia serrata
About 10 g of H. serrata was crushed with a grinder and
heated with 100 mL chloroform for 2 h. The chloroform
was removed by using the rotary vacuum evaporator.
The residues obtained were dissolved in 0.01 M HCl
and extracted twice with chloroform. The pH of the
water solute was adjusted to 10 by adding 1 M NaOH to
the mixture. Then the extract was extracted with chlo-
roform twice again. The chloroform-solute was col-
lected and lyophilized before use.
Immobilized Enzyme Recycling
To allow repeating screening, the enzymes were recy-
cled. After enzymatic reaction, the supernatant was
removed for analysis via MS. Three 200-L washes of
incubation buffer were added to the residual micro-
pheres followed by light shaking and removal of the
supernatant. The immobilized enzymes were then de-
natured to release the bound compounds. The denatur-
ing wash was performed by adding two 200-L aliquots
of MeOH to the immobilized enzyme microspheres and
heating at 65 °C for 10 min, followed by isolation and
collection of the supernatant with use of the magnet.
The MeOH washes were combined and vacuum centri-
fuged to dryness.
Results and Discussion
Performance of Immobilized Acetylcholinesterase
The magnetite microspheres synthesized via the solvo-
thermal reaction had a mean diameter of about 300 nm
(Figure S1a, supporting information, which can be
found in the electronic version of this article) according
to the transmission electron microscope (TEM) observa-
tion. After being coated with silica through the sol-gel
approach, core-shell structured magnetic silica micro-
spheres with single magnetite core and uniform silica
shell (70 nm in thickness) were obtained (Fig. S1b,
supporting information). The thick silica shell was
formed uniformly, thus providing magnetic micro-
spheres with a silica-like surface for further modifica-
tion. GLYMO was chosen as the derivative reagent for
magnetic silica microspheres. By comparison with other
reactive “spacer” groups such as diol, aldehyde, and
tresyl groups, the epoxy group shows better immobili-
zation ratio and ability of the enzyme for structural
recognition [46]. Fourier transfer infrared (FT-IR) spec-
troscopy characterization confirmed the successful
modification of the magnetic silica microspheres by
GLYMO molecules (Figure S2, supporting information).
The immobilization ability of GLYMO-modified mag-
netic silica microspheres for AChE immobilization wasdetermined by measuring the UV absorption value of
the supernatant enzyme solution after the immobiliza-
tion procedure. The amount of AChE immobilized on
the magnetic microparticles was calculated to be about
50 g/mg.
Figure 1 shows the process of the AChE assay:
AChE-coated MS microspheres were transferred to a 0.6
mL EP tube and dispersed in buffer solution. After
being incubated with substrate ACh under 37 °C for an
appropriate time, the reactant can be quickly and easily
separated while the magnetic silica microspheres were
retained by magnet. Equation 1 (Figure 1b) shows what
happened in the enzyme-substrate mixture. Finally,
ESI-MS was applied to detect the release of product.
Acetylcholinesterase (AChE) can rapidly hydrolyze ace-
tylcholine (ACh, m/z146.1) into choline (m/z 104.1) and
acetic acid. Provided the substrate was hydrolyzed to
be a product, two special ion peaks at m/z 146.1 and
104.1 can be found in the MS spectrum. Easy manipu-
lation was set up since there was no particular require-
ment of separation technique.
Before investigating the performance of the immobi-
lized enzyme, the conditions for incubation or digestion
were compared and optimized. To achieve optimum
compatibility between the biochemical assay and MS
detection conditions, 10 mM NH4HCO3 was selected to
be the incubation buffer. Then, three enzymatic hydrol-
yses with different digestion times—15, 30, and 60
min—were compared in terms of enzyme activity,
which is the ratio of ion intensity of the substrate to an
internal standard (chlormequat). After hydrolysis for 15
min, the enzyme activity was 15% lower than that of 30-
and 60-min hydrolyses. Figure 2 shows their typical MS
spectrum together with their comparison of enzyme
activity. However, with 60-min hydrolysis, no apparent
increase of activity was observed. Thus, 30 min should
be the optimum incubation time for the enzymatic
hydrolysis.
Furthermore, to test the performance of the immobi-
lized enzyme, we compared the hydrolysis effect of the
normal enzyme in solution. The assay with free enzyme
was performed as follows: mixtures of 5 g AChE and
substrate were incubated for 30 min at 37 °C; then 20 L
acetonitrile was added to terminate the reaction.
Amounts of AChE and ACh were identical to those of
the immobilized enzyme. Figure 3 shows the behavior
of the immobilized enzyme and the free enzyme
through comparison of the ratio of peak intensity of
acetylcholine to chlormequat. Three replicate assays
with each enzyme were performed. It seems that the
immobilized enzyme exerts a greater effect than that of
free enzyme. Since the MS microspheres have a large
surface area, the high concentration of immobilized
enzyme would be achieved at a certain volume. Thus,
the substrate might be in contact with AChE for a
longer time compared with that of the solute system
[47]. Another advantage of the immobilized enzyme
here is that there is no need of an organic solvent, which
may result in possible interference on MS.
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Activity
Semiquantitative analysis of low-mass compounds by
ESI-MS has been previously described in detail [39, 40].
Here, semiquantitative monitoring of immobilized en-
zyme activity through ESI-MS was demonstrated. As a
structural analog, chlormequat was chosen as the internal
Figure 2. Mass spectrum of ACh hydrolyzed b
(b) 30 min, and (c) 60 min. Buffer: 10 mM NH4H
conditions.
Figure 3. Comparison of enzyme activity throu
in solution. Buffer: 10 mM NH HCO . Incubatio4 3
intensity of substrate to internal standard. The errorstandard for quantitative analysis of acetylcholine and
choline. The relative standard deviation of five indepen-
dent evaluations of 20 M acetylcholine (with the internal
standard of 20M) was less than 10% (figures not shown).
Using the method of ESI-MS to detect the reaction of
hydrolyzing acetylcholine to choline catalyzed by im-
mobilized acetylcholinesterase in vitro was quantita-
obilized AChE under different time: (a) 15 min
(d) Comparison of enzyme activity under above
drolysis by immobilized AChE and free enzyme
e: 30 min. Every bar represents the ratio of iony imm
CO .gh hy
n timbar indicate standard deviations (n  3).
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ing reaction is observed through the appearance of
choline and reduction of acetylcholine. Under opti-
mized condition, acetylcholine is hydrolyzed to choline
within 30 min. Activity of the immobilized enzyme was
determined by the ratio of peak intensity of acetylcho-
line to chlormequat. Chlormequat was used not only as
an internal standard for semiquantitative analysis but
also as a standard to evaluate spectrum quality.
Recycling and Reuse of Enzyme
After enzymatic hydrolysis, the AChE-coated micro-
spheres were quickly gathered and removed by use of a
magnet. Then, three 200-L washes of incubation buffer
were added to the micropheres followed by light shak-
ing and removal of the supernatant. The immobilized
enzymes were then renewed and can once again be
used to catalyze the enzymatic reaction.
The reproducibility of the immobilized enzyme was
investigated through five consecutive assays for ACh
with incubation for 30 min at 37 °C using the same
immobilized AChE. The results were then analyzed by
ESI-MS. Figure 4 shows the enzyme activity of five
successive enzymatic reactions catalyzed by the same
group of enzyme-coated microspheres. The activity of
immobilized enzyme, in terms of the ratio of ion inten-
sity of substrate to internal standard, is evaluated in the
form of a bar chart in Figure 4. The acetylcholinesterase
immobilized onto GLYMO-modified MS microspheres
remained active during the five hydrolysis reactions
with little difference among the five spectra. Thus it
should be inferred that the activity of immobilized
enzyme is guaranteed even after five repeatable appli-
cations. It should be noted that, although only a small
amount of enzyme had been immobilized onto the
microspheres, its performance was sufficiently high to
Figure 4. Comparison of enzyme activity from
lized enzyme microspheres. The activity was calc
standard.rapidly catalyze the reaction and maintain good repeat-ability. Recycling of enzyme can enhance a material’s
efficiency, thus decreasing the test cost.
When stored at 4 °C, the stability of the AChE-
immobilized MS microspheres seemed excellent. In
detail, three groups of AChE were immobilized onto
silica microspheres on the first day. The first group was
used to hydrolyze the substrate on the first day. The
second and third groups were applied to enzymatic
hydrolysis on the third day and fifth day, respectively.
The ratio of ion intensity of substrate to internal stan-
dard is shown in Figure 5. Since the ratio scarcely
changes (RSD 3%), it seems that the activity of immo-
bilized acetylcholinesterase was not diminished when
stored at 4 °C. The ability of the enzyme to adhere to
GLYMO-modified silica magnetic microspheres was so
strong that the enzyme still catalyzed the reaction very
effectively over a long period of storage (5 days).
Consequently, the immobilized enzyme model may
reduce the cost of testing since the enzyme-coated
microspheres can be recycled but still maintain good
reproducibility and stability. The immobilized enzyme
behaves more effectively than the enzyme in solution.
Inhibitor Screening
Hup A and Hup B have proved to be promising drugs
in the treatment of AD. The key mechanism of their
treatment is the inhibition effect on acetylcholinester-
ase. Here, we select them to serve as the standard drugs
to develop an enzyme inhibitor screening model. The
model process was shown earlier in Figure 1c: AChE-
immobilized microspheres were well dispersed in the
buffer; they were then incubated with substrate and
analyte (Hup A or Hup B) at 37 °C for 30 min; quickly
isolated with use of a magnet; and finally the superna-
tant was detected by ESI-MS. Equation 2 (Figure 1c)
shows what occurs in the enzyme–substrate–analyte
AChE assays reacted with the reused immobi-
d by ratio of ion intensity of substrate to internalfive
ulatemixture. If the analyte takes effect, the enzyme will be
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The change expressed in the MS spectra is that the ion
intensity of the peak at m/z 104.1 (product) will become
weaker or disappear. The intensity varies with the
drug’s pharmaceutical effect. Figure 6a, b shows the
mass spectra of the assay with Hup A and Hup B. The
product’s peak vanishes in Figure 6a, b, suggesting that
Hup A and Hup B were apparently strong inhibitors for
AChE. This result is in agreement with that reported in
Figure 5. Comparison of enzyme activity fro
enzyme immobilized on the first day. Enzyme ac
standard deviations (n  3).
Figure 6. Typical MS spectra for screening in
serrata. (d) Control, mixture of H. serrata and substraother studies [30–32]. Peaks at m/z 243.1 and 257.1
imply the existence of Hup A (MS: 242) and Hup B (MS:
256).
By relating the assay for activity (Figure 1b, eq 1) and
that for inhibition (Figure 1c, eq 2), we may illustrate a
simple principle of how the inhibitors exert their influ-
ence on enzymatic hydrolysis. It can be explained by
the key-lock theory. The enzyme is like a lock and the
substrate is like a key, so structural characteristics of the
ery two days’ AChE assays reacted with the
was evaluated as above. The error bar indicate
rs in (a) Hup A, (b) Hup B, and (c) Huperziam ev
tivityhibito
te.
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For AChE and ACh, the relationship is expressed as a
negative-ion structure in enzyme and a positive-ion
structure (quaternary ammonium ion) in substrate. As
shown in Figure 1 (bottom), the enzyme is pictured as a
sector loss of a quarter whose form is similar to the
corner in the substrate. This mutual structure leads to
their possible contact, thus forming an enzyme–sub-
strate complex. Afterward, the hydrolysis reaction oc-
curs since the choline disappears from the complex.
Enzyme and inhibitors may also be characterized as a
lock and key combination. Inhibitors also have a related
corner. As a result, substrate and inhibitor will compete
against each other to contact the enzyme. Such compe-
tition will somewhat reduce the probability of combin-
ing enzyme with substrate.
To investigate the effect of the aforementioned inhib-
itor screening model, it was performed on a compli-
cated sample. The Chinese herbal Huperzia serrata, the
source of Hup A and Hup B, should contain several
bioactive compounds that inhibit the activity of AChE.
An extract of the herbal was incubated with the immo-
bilized enzyme and substrate. The result is demon-
strated in the MS spectrum shown in Figure 6c. Figure
6d shows the MS spectrum of the mixture with sub-
strate and H. serrata. By comparing these two spectra, it
can be concluded that the herbal inhibits acetylcholines-
terase with the integrative effect of several compounds
besides Hup A and Hup B since several peaks disap-
peared. There are other constituent parts of the herbal
that are worthy of further investigation, especially for
pharmaceutical study. Above all, the inhibitor screen-
ing model can be applied without limitation to a
complicated system.
Conclusions
A novel method for screening the AChE inhibitor was
established, based on ESI-MS and AChE immobilized
onto magnetic silica microspheres. Due to the fast and
efficient removal of the enzyme-coated magnetic micro-
spheres with the use of a magnet, the previous enzyme
allows one to analyze the reactant without any kind of
separation and purification. Compared to an in-solution
enzyme, the immobilized enzyme can be recycled and
reused up to five times based on its good reproducibil-
ity and stability. This leads to the possibility of reduced
cost. Some of the new features presenting here demon-
strate that the immobilization enzyme onto magnetic
microspheres is able to directly replace the common
form of enzyme digestions and can be applied to
pharmaceutical study with no apparent limitations.
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